Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$969M |
| 2 |
Abbott
ABT
|
+$958M |
| 3 |
Gilead Sciences
GILD
|
+$794M |
| 4 |
GE Aerospace
GE
|
+$748M |
| 5 |
Costco
COST
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$3.38B |
| 2 |
Apple
AAPL
|
+$1.64B |
| 3 |
Truist Financial
TFC
|
+$1.09B |
| 4 |
Booking.com
BKNG
|
+$1.05B |
| 5 |
Alibaba
BABA
|
+$956M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 14.32% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Communication Services | 11.77% |
| 5 | Financials | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZR
201
DELISTED
Caesars Entertainment Corporation
CZR
| $260M | 0.08% |
20,574,596
+14,608,358
| +245% | +$185M |
|
|
CBPO
202
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $258M | 0.08% |
3,280,964
+3,925
| +0.1% | +$326K |
|
203
Emerson Electric
EMR
$91.4B
| $257M | 0.08% |
3,681,850
| – | – |
|
|
FNSR
204
DELISTED
Finisar Corp
FNSR
| $256M | 0.08% |
12,578,845
-1,072,205
| -8% | -$22.3M |
|
205
Conagra Brands
CAG
$7.16B
| $254M | 0.07% |
6,747,200
-1,146
| -0% | -$40.7K |
|
206
Generac Holdings
GNRC
$13.1B
| $254M | 0.07% |
5,127,910
-44,431
| -0.9% | -$2.21M |
|
|
SBNY
207
DELISTED
Signature Bank
SBNY
| $253M | 0.07% |
1,844,486
+121
| +0% | +$15.9K |
|
208
Public Storage
PSA
$60.4B
| $250M | 0.07% |
1,195,255
+94,255
| +9% | +$19.9M |
|
209
Ford
F
$55.1B
| $250M | 0.07% |
20,000,000
-3,655,000
| -15% | -$45M |
|
210
ConocoPhillips
COP
$153B
| $247M | 0.07% |
4,495,600
-7,052,188
| -61% | -$363M |
|
|
MLNX
211
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $247M | 0.07% |
3,811,933
+796,334
| +26% | +$42.1M |
|
212
Valvoline
VVV
$4.25B
| $246M | 0.07% |
9,824,397
+4,840,086
| +97% | +$117M |
|
|
ATHN
213
DELISTED
Athenahealth, Inc.
ATHN
| $244M | 0.07% |
1,835,714
-186,000
| -9% | -$23.8M |
|
214
Omnicom Group
OMC
$23.5B
| $241M | 0.07% |
3,308,701
+13
| +0% | +$933 |
|
215
Landstar System
LSTR
$6.31B
| $237M | 0.07% |
2,279,662
+234
| +0% | +$23.5K |
|
216
Televisa
TV
$1.49B
| $234M | 0.07% |
12,550,700
+1,858,700
| +17% | +$38.5M |
|
217
Ultragenyx Pharmaceutical
RARE
$2.65B
| $231M | 0.07% |
4,985,005
+895,266
| +22% | +$43.9M |
|
218
Agnico Eagle Mines
AEM
$93.8B
| $231M | 0.07% |
5,003,412
| – | – |
|
219
Williams-Sonoma
WSM
$28.9B
| $230M | 0.07% |
8,902,614
+760
| +0% | +$19.4K |
|
220
TJX Companies
TJX
$169B
| $223M | 0.07% |
5,821,146
+16
| +0% | +$580 |
|
221
Occidental Petroleum
OXY
$58.5B
| $221M | 0.06% |
3,000,000
| – | – |
|
222
Hilton Grand Vacations
HGV
$3.49B
| $221M | 0.06% |
5,256,786
+578,586
| +12% | +$23.5M |
|
223
NextEra Energy
NEE
$179B
| $210M | 0.06% |
5,380,784
-1,148,068
| -18% | -$44.3M |
|
224
Kosmos Energy
KOS
$1.49B
| $210M | 0.06% |
30,623,595
+116,464
| +0.4% | +$887K |
|
|
MRSH
225
Marsh
MRSH
$90.1B
| $205M | 0.06% |
2,514,053
-244
| -0% | -$20.3K |
|
Similar funds
Capital Research Global Investors's Q4 2017 Portfolio in Review
As of Q4 2017, Capital Research Global Investors held 456 positions worth $341B, up 2.9% from $331B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors withdrew a net $12B in Q4 2017, closing 24 positions and reducing 153 holdings. Its most notable exit was Valero Energy, an estimated $292M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Capital Research Global Investors opened a new position in Middleby worth $266M.
- Capital Research Global Investors's largest Q4 2017 buy was Middleby: 1,967,973 shares worth $266M.
- Capital Research Global Investors added most to Nike in Q4 2017, an estimated $969M increase.
- Capital Research Global Investors's biggest Q4 2017 reduction was Oracle, cutting an estimated $3.38B.
- Capital Research Global Investors fully exited Valero Energy in Q4 2017, selling an estimated $292M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $341B portfolio in Q4 2017.
- Capital Research Global Investors opened 23 new positions and closed 24 in Q4 2017.
- Capital Research Global Investors's portfolio value rose 2.9% quarter-over-quarter to $341B.
Based on Capital Research Global Investors's 13F filing for Q4 2017, filed 14 Feb 2018.